<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yamada H</submitter><funding>Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)</funding><funding>Princess Takamatsu Cancer Research Fund</funding><funding>Magnetic Health Science Foundation</funding><funding>Daiwa Securities Health Foundation</funding><funding>SEI Group CSR Foundation</funding><funding>Innovative Techno-Hub for Integrated Medical Bio-Imaging of the Project for Developing Innovation Systems</funding><funding>JSPS</funding><pagination>125-8</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4906467</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5(2)</volume><pubmed_abstract>In an attempt to monitor μm-level trace constituents, we applied here (1)H-{(13)C-(15)N} triple-resonance nuclear magnetic resonance (NMR) to (13)C/(15)N-enriched l-Dopa as the inevitable precursor of the neurotransmitter dopamine in the brain. The perfect selectivity (to render endogenous components silent) and μm-level sensitivity (700 MHz spectrometer equipped with a cryogenic probe) of triple-resonance allowed the unambiguous and quantitative metabolic and pharmacokinetic analyses of administered l-Dopa/dopamine in the brain and liver of mice. The level of dopamine generated in the brain (within the range 7-76 μm, which covers the typical stimulated level of ∼30 μm) could be clearly monitored ex vivo, but was slightly short of the detection limit of a 7 T MR machine for small animals. </pubmed_abstract><journal>ChemistryOpen</journal><pubmed_title>(13)C/(15)N-Enriched l-Dopa as a Triple-Resonance NMR Probe to Monitor Neurotransmitter Dopamine in the Brain and Liver Extracts of Mice.</pubmed_title><pmcid>PMC4906467</pmcid><funding_grant_id>15K01819</funding_grant_id><funding_grant_id>25350977</funding_grant_id><funding_grant_id>15H01403</funding_grant_id><pubmed_authors>Kimura Y</pubmed_authors><pubmed_authors>Kondo T</pubmed_authors><pubmed_authors>Matsuda T</pubmed_authors><pubmed_authors>Toshimitsu A</pubmed_authors><pubmed_authors>Sando S</pubmed_authors><pubmed_authors>Aoyama Y</pubmed_authors><pubmed_authors>Yamada H</pubmed_authors><pubmed_authors>Imai H</pubmed_authors><pubmed_authors>Kameda T</pubmed_authors></additional><is_claimable>false</is_claimable><name>(13)C/(15)N-Enriched l-Dopa as a Triple-Resonance NMR Probe to Monitor Neurotransmitter Dopamine in the Brain and Liver Extracts of Mice.</name><description>In an attempt to monitor μm-level trace constituents, we applied here (1)H-{(13)C-(15)N} triple-resonance nuclear magnetic resonance (NMR) to (13)C/(15)N-enriched l-Dopa as the inevitable precursor of the neurotransmitter dopamine in the brain. The perfect selectivity (to render endogenous components silent) and μm-level sensitivity (700 MHz spectrometer equipped with a cryogenic probe) of triple-resonance allowed the unambiguous and quantitative metabolic and pharmacokinetic analyses of administered l-Dopa/dopamine in the brain and liver of mice. The level of dopamine generated in the brain (within the range 7-76 μm, which covers the typical stimulated level of ∼30 μm) could be clearly monitored ex vivo, but was slightly short of the detection limit of a 7 T MR machine for small animals. </description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Apr</publication><modification>2025-04-19T23:19:01.218Z</modification><creation>2019-03-27T02:15:58Z</creation></dates><accession>S-EPMC4906467</accession><cross_references><pubmed>27308224</pubmed><doi>10.1002/open.201500196</doi></cross_references></HashMap>